Besivance
- Product NDC
- 50090-1241
- 11-digit product format
- 500901241
- Labeler code
- 50090
- Product ID
- 50090-1241_354afd39-0900-4c16-be1a-e47978ab280c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Besifloxacin
- Dosage form
- SUSPENSION
- Route
- OPHTHALMIC
- Labeler
- A-S Medication Solutions
- Application
- NDA022308
- Marketing category
- NDA
- Marketing start
- 2009-05-28
- Marketing end
- 0000-00-00
- Substance
- BESIFLOXACIN
- Active strength
- 6 mg/mL
- Pharmacologic classes
- Quinolone Antimicrobial [EPC],Quinolones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-1241 | BESIVANCE (BESIFLOXACIN) SUSPENSION [A-S MEDICATION SOLUTIONS] | 13 | Legacy NDC | 20230726_b111b1ab-10b0-4378-8aef-e51d5274306c.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-1241-0 | 50090124100 | 1 BOTTLE, DROPPER in 1 CARTON (50090-1241-0) > 5 mL in 1 BOTTLE, DROPPER | 2014-11-28 | 0000-00-00 | No | No | Current |